Multiplex gene editing to target the roots of hepatitis B virus infection

MOLECULAR THERAPY NUCLEIC ACIDS · Published 2026-08-03 · DOI 10.1016/j.omtn.2026.103026

Free full text

Authors (2)

Anuj Kumar, Fabien Zoulim

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Kumar, A., Zoulim, F. (2026). Multiplex gene editing to target the roots of hepatitis B virus infection. MOLECULAR THERAPY NUCLEIC ACIDS. https://doi.org/10.1016/j.omtn.2026.103026

Related articles

• Multiplex gene editing suppresses random integration of hepatitis B virus DNA in chronically infected liver · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Cites or is cited by this article · Same journal
• Understanding HBV immunopathogenesis to inform future immune-based therapies · ANTIVIRAL RESEARCH · 2026 · Cites or is cited by this article
• Decoding preeclampsia: A fusion of multi-view machine learning and multi-omics to identify putative inflammation-related mechanisms · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Y-RNAs and their fragments reflect kidney injury in diabetic kidney disease · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Quieting the carrier: Matching delivery to immunology in anti-inflammatory mRNA therapy · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Polyamines are i-Motif disruptors · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Codon-Optimized Npc1 mRNA corrects Niemann-Pick type C1 disease phenotypes in vitro and in vivo · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Neonatal expression of human FMRP isoform corrects cortical deficits and improves behavior in a mouse model of fragile X syndrome · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Intranasal Tat-modified PEG-PCL nanomicelles delivering anti-RelA siRNA attenuate ischemia-reperfusion injury in transient MCAO mice · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal
• Antisense Peptide Nucleic Acids Targeting Ribosomal Protein Genes: A Novel Strategy Against Carbapenem-resistant Acinetobacter baumannii · MOLECULAR THERAPY NUCLEIC ACIDS · 2026 · Same journal